A 58-year-old man with a 40 pack-year smoking history lives on a remote First Nations reserve with limited access to diagnostic imaging. He has stable COPD (GOLD stage 2) and is on a long-acting muscarinic antagonist. He asks about screening for lung cancer. What is the most appropriate response?